Zimmer Biomet said shareholders approved the amended Employee Stock Purchase Plan (ESPP) at its annual meeting on May 10, 2024. The board approved the proposed amendments and directed that they be submitted to shareholders for approval in February 2024.

1. 01

   Zimmer Biomet said shareholders approved the amended Employee Stock Purchase Plan (ESPP) at its annual meeting on May 10, 2024. The board approved the proposed amendments and directed that they be submitted to shareholders for approval in February 2024.

2. 02

   The company said the amended ESPP increases the number of shares available for issuance and purchase by participants by 10,000,000 million shares, and modifies certain other provisions to facilitate administration and implement best practice changes.

3. 03

   The company reported vote results for the amended ESPP (Proposal 4): 171,503,181 votes for, 603,453 against, 178,037 abstentions and 14,430,099 broker non-votes.

4. 04

   Zimmer Biomet said shareholders elected 10 directors on May 10, 2024 to one-year terms ending at the 2025 annual meeting, a 1-year term, and ratified the Audit Committee's appointment of PricewaterhouseCoopers LLP as the independent registered public accounting firm for 2024.

Analysis scope · Filing bodyWe analyzed the filing body and confirmed exhibits. This is not a review of other exhibits, investor presentations or the full earnings call.

AI summarized the filing and translated the summary into English; it may differ from the original. For reference only, not investment advice. AI translated the published Korean report into English. Figures are copied as filed, not recalculated.

Original filing

The filing as submitted to SEC EDGAR. You can check the figures and statements of this summary against it.